Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1970 Oct 31;4(5730):259–265. doi: 10.1136/bmj.4.5730.259

Cancer chemotherapy--the first twenty-five years.

R B Scott
PMCID: PMC1819834  PMID: 4319950

Full text

PDF
260

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARNOLD H., BOURSEAUX F., BROCK N. Chemotherapeutic action of a cyclic nitrogen mustard phosphamide ester (B 518-ASTA) in experimental tumours of the rat. Nature. 1958 Mar 29;181(4613):931–931. doi: 10.1038/181931a0. [DOI] [PubMed] [Google Scholar]
  2. Angier R. B., Boothe J. H., Hutchings B. L., Mowat J. H., Semb J., Stokstad E. L., Subbarow Y., Waller C. W., Cosulich D. B., Fahrenbach M. J., Hultquist M. E., Kuh E., Northey E. H., Seeger D. R., Sickels J. P., Smith J. M., Jr The Structure and Synthesis of the Liver L. casei Factor. Science. 1946 May 31;103(2683):667–669. doi: 10.1126/science.103.2683.667. [DOI] [PubMed] [Google Scholar]
  3. BAGSHAWE K. D. TROPHOBLASTIC TUMOURS. CHEMOTHERAPY AND DEVELOPMENTS. Br Med J. 1963 Nov 23;2(5368):1303–1307. doi: 10.1136/bmj.2.5368.1303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BAILEY W. C., HOLADAY W. J., KONTRAS S. B., CLATWORTHY W. W., Jr Rhabdomyosarcomas in childhood. A review of 14 cases. Arch Surg. 1961 Jun;82:943–949. doi: 10.1001/archsurg.1961.01300120157018. [DOI] [PubMed] [Google Scholar]
  5. BASERGA R. THE RELATIONSHIP OF THE CELL CYCLE TO TUMOR GROWTH AND CONTROL OF CELL DIVISION: A REVIEW. Cancer Res. 1965 Jun;25:581–595. [PubMed] [Google Scholar]
  6. BOLLAG W., GRUNBERG E. Tumour inhibitory effects of a new class of cytotoxic agents: methylhydrazine derivatives. Experientia. 1963 Mar 15;19:130–131. doi: 10.1007/BF02171589. [DOI] [PubMed] [Google Scholar]
  7. BROCK N. Experimentelle Grundlagen der Chemotherapie des Krebses; Biochemische, pharmakologische und histo-pathologische Untersuchungen mit N-Oxyd-Lost. Arzneimittelforschung. 1957 Dec;7(12):727–735. [PubMed] [Google Scholar]
  8. BROWN J. H., KENNEDY B. J. MITHRAMYCIN IN THE TREATMENT OF DISSEMINATED TESTICULAR NEOPLASMS. N Engl J Med. 1965 Jan 21;272:111–118. doi: 10.1056/NEJM196501212720301. [DOI] [PubMed] [Google Scholar]
  9. BURCHENAL J. H., MURPHY M. L., ELLISON R. R., SYKES M. P., TAN T. C., LEONE L. A., KARNOFSKY D. A., CRAVER L. F., DARGEON H. W., RHOADS C. P. Clinical evaluation of a new antimetabolite, 6-mercaptopurine, in the treatment of leukemia and allied diseases. Blood. 1953 Nov;8(11):965–999. [PubMed] [Google Scholar]
  10. Backhouse T. W., Sicher K. Initial experiences with methylhydrazine, a new cytotoxic agent. Clin Radiol. 1966 Apr;17(2):132–135. doi: 10.1016/s0009-9260(66)80073-9. [DOI] [PubMed] [Google Scholar]
  11. Bagshawe K. D. Tumour growth and anti-mitotic action. The role of spontaneous cell losses. Br J Cancer. 1968 Dec;22(4):698–713. doi: 10.1038/bjc.1968.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Beard M. E., Crowther D., Galton D. A., Guyer R. J., Fairley G. H., Kay H. E., Knapton P. J., Malpas J. S., Scott R. B. L-asparaginase in treatment of acute leukaemia and lymphosarcoma. Br Med J. 1970 Jan 24;1(5690):191–195. doi: 10.1136/bmj.1.5690.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Boiron M., Weil M., Jacquillat C., Tanzer J., Levy D., Sultan C., Bernard J. Daunorubicin in the treatment of acute myelocytic leukaemia. Lancet. 1969 Feb 15;1(7590):330–333. doi: 10.1016/s0140-6736(69)91296-3. [DOI] [PubMed] [Google Scholar]
  14. Bonadonna G., Monfardini S., De Lena M., Fossati-Bellani F. Clinical evaluation of adriamycin, a new antitumour antibiotic. Br Med J. 1969 Aug 30;3(5669):503–506. doi: 10.1136/bmj.3.5669.503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Bornstein R. S., Theologides A., Kennedy B. J. Daunorubicine in acute myelogenous leukemia in adults. JAMA. 1969 Feb 17;207(7):1301–1306. [PubMed] [Google Scholar]
  16. Bruce W. R., Meeker B. E. Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to tritiated thymidine. J Natl Cancer Inst. 1965 Jun;34(6):849–856. [PubMed] [Google Scholar]
  17. Bruce W. R., Meeker B. E., Valeriote F. A. Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo. J Natl Cancer Inst. 1966 Aug;37(2):233–245. [PubMed] [Google Scholar]
  18. Burchenal J. H., Adams H. H., Newell N. S., Fox J. J. Comparative activity of 1-beta-d-arabinofuranosyl-5-fluorocytosine and related compounds against transplanted mouse leukemias in vivo and in vitro. Cancer Res. 1966 Mar;26(3):370–373. [PubMed] [Google Scholar]
  19. Burchenal J. H., Karnofsky D. A. Clinical evaluation of L-asparaginase. Introduction. Cancer. 1970 Feb;25(2):241–243. doi: 10.1002/1097-0142(197002)25:2<241::aid-cncr2820250202>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  20. COLE J. W., McKALEN A. Observations of cell renewal in human rectal mucosa in vivo with thymidine-H3. Gastroenterology. 1961 Aug;41:122–125. [PubMed] [Google Scholar]
  21. CUTTS J. H., BEER C. T., NOBLE R. L. Biological properties of Vincaleukoblastine, an alkaloid in Vinca rosea Linn, with reference to its antitumor action. Cancer Res. 1960 Aug;20:1023–1031. [PubMed] [Google Scholar]
  22. Clarkson B., Krakoff I., Burchenal J., Karnofsky D., Golbey R., Dowling M., Oettgen H., Lipton A. Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors. Cancer. 1970 Feb;25(2):279–305. doi: 10.1002/1097-0142(197002)25:2<279::aid-cncr2820250205>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  23. Cooper E. H., Frank G. L., Wright D. H. Cell proliferation in Burkitt tumours. Eur J Cancer. 1966 Dec;2(4):377–384. doi: 10.1016/0014-2964(66)90052-1. [DOI] [PubMed] [Google Scholar]
  24. DIMARCO A., GAETANI M., DORIGOTTI L., SOLDATI M., BELLINI O. STUDI SPERIMENTALI SULL'ATTIVITA' ANTINEOPLASTICA DEL NUOVO ANTIBIOTICO DAUNOMICINA. Tumori. 1963 May-Jun;49:203–217. [PubMed] [Google Scholar]
  25. DUBOST M., GANTER P., MARAL R., NINET L., PINNERT S., PREUDHOMME J., WERNER G. H. UN NOUVEL ANTIBIOTIQUE 'A PROPRI'ET'ES CYTOSTATIQUES: LA RUBIDOMYCINE. C R Hebd Seances Acad Sci. 1963 Sep 9;257:1813–1815. [PubMed] [Google Scholar]
  26. DeVita V. T., Serpick A., Carbone P. P. Preliminary clinical studies with ibenzmethyzin. Clin Pharmacol Ther. 1966 Jul-Aug;7(4):542–546. doi: 10.1002/cpt196674542. [DOI] [PubMed] [Google Scholar]
  27. Dolowy W. C., Henson D., Cornet J., Sellin H. Toxic and antineoplastic effects of L-asparaginase. Study of mice with lymphoma and normal monkeys and report on a child with leukemia. Cancer. 1966 Dec;19(12):1813–1819. doi: 10.1002/1097-0142(196612)19:12<1813::aid-cncr2820191208>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  28. ELSON L. A. A comparison of the effects of radiation and radiomimetic chemicals on the blood. Br J Haematol. 1955 Jan;1(1):104–116. doi: 10.1111/j.1365-2141.1955.tb05492.x. [DOI] [PubMed] [Google Scholar]
  29. EVANS A. E., FARBER S., BRUNET S., MARIANO P. J. VINCRISTINE IN THE TREATMENT OF ACUTE LEUKEMIA IN CHILDREN. Cancer. 1963 Oct;16:1302–1306. doi: 10.1002/1097-0142(196310)16:10<1302::aid-cncr2820161011>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  30. FARBER S., D'ANGIO G., EVANS A., MITUS A. Clinical studies on actinomycin D with special reference to Wilms' tumor in children. Ann N Y Acad Sci. 1960 Oct 5;89:421–425. doi: 10.1111/j.1749-6632.1960.tb20165.x. [DOI] [PubMed] [Google Scholar]
  31. FARBER S., PINKEL D., SEARS E. M., TOCH R. Advances in chemotherapy of cancer in man. Adv Cancer Res. 1956;4:1–71. doi: 10.1016/s0065-230x(08)60721-6. [DOI] [PubMed] [Google Scholar]
  32. GALTON D. A., TILL M. Myleran in chronic myeloid leukaemia. Lancet. 1955 Feb 26;268(6861):425–430. doi: 10.1016/s0140-6736(55)90212-9. [DOI] [PubMed] [Google Scholar]
  33. GALTON D. A., WILTSHAW E., SZUR L., DACIE J. V. The use of chlorambucil and steroids in the treatment of chronic lymphocytic leukaemia. Br J Haematol. 1961 Jan;7:73–98. doi: 10.1111/j.1365-2141.1961.tb00321.x. [DOI] [PubMed] [Google Scholar]
  34. Gee T. S., Yu K. P., Clarkson B. D. Treatment of adult acute leukemia with arabinosylcytosine and thioguanine. Cancer. 1969 May;23(5):1019–1032. doi: 10.1002/1097-0142(196905)23:5<1019::aid-cncr2820230506>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  35. Gilman A., Philips F. S. The Biological Actions and Therapeutic Applications of the B-Chloroethyl Amines and Sulfides. Science. 1946 Apr 5;103(2675):409–436. doi: 10.1126/science.103.2675.409. [DOI] [PubMed] [Google Scholar]
  36. Goudemand M., Sautière-Habay D., Bauters F., Lerche-Habart B. Le traitement des leucémies aiguës myéloblastiques par la rubidomycine. A propos d'une statistique de 35 cas. Lille Med. 1969 Mar;14(3):257–263. [PubMed] [Google Scholar]
  37. HAAR H., MARSHALL G. J., BIERMAN H. R., STEINFELD J. L. The influence of cyclophosphamide upon neoplastic diseases in man. Cancer Chemother Rep. 1960 Feb;6:41–51. [PubMed] [Google Scholar]
  38. HADDOW A., TIMMIS G. M. Bifunctional sulphonic acid esters with radiomimetic activity. Acta Unio Int Contra Cancrum. 1951;7(3):469–471. [PubMed] [Google Scholar]
  39. HADDOW A., TIMMIS G. M. Myleran in chronic myeloid leukaemia; chemical constitution and biological action. Lancet. 1953 Jan 31;264(6753):207–208. doi: 10.1016/s0140-6736(53)90884-8. [DOI] [PubMed] [Google Scholar]
  40. HARBERS E., CHAUDHURI N. K., HEIDELBERGER C. Studies on fluorinated pyrimidines. VIII. Further biochemical and metabolic investigations. J Biol Chem. 1959 May;234(5):1255–1262. [PubMed] [Google Scholar]
  41. HERTZ R., ROSS G. T., LIPSETT M. B. CHEMOTHERAPY IN WOMEN WITH TROPHOBLASTIC DISEASE: CHORIOCARCINOMA, CHORIOADENOMA DESTRUENS, AND COMPLICATED HYDATIDIFORM MOLE. Ann N Y Acad Sci. 1964 Apr 2;114:881–885. [PubMed] [Google Scholar]
  42. HYMAN C. B., BOGLE J. M., BRUBAKER C. A., WILLIAMS K., HAMMOND D. CENTRAL NERVOUS SYSTEM INVOLVEMENT BY LEUKEMIA IN CHILDREN. I. RELATIONSHIP TO SYSTEMIC LEUKEMIA AND DESCRIPTION OF CLINICAL AND LABORATORY MANIFESTATIONS. Blood. 1965 Jan;25:1–12. [PubMed] [Google Scholar]
  43. Hammond C. B., Hertz R., Ross G. T., Lipsett M. B., Odell W. D. Primary chemotherapy for nonmetastatic gestational trophoblastic neoplasms. Am J Obstet Gynecol. 1967 May 1;98(1):71–78. doi: 10.1016/0002-9378(67)90134-2. [DOI] [PubMed] [Google Scholar]
  44. Hansen M. M., Hertz H., Videaek A. Use of a methyl hydrazine derivative (natulan), especially in Hodgkin's disease. Acta Med Scand. 1966 Aug;180(2):211–224. doi: 10.1111/j.0954-6820.1966.tb02827.x. [DOI] [PubMed] [Google Scholar]
  45. Hill J. M., Roberts J., Loeb E., Khan A., MacLellan A., Hill R. W. L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia. JAMA. 1967 Nov 27;202(9):882–888. [PubMed] [Google Scholar]
  46. Howard J. P., Cevik N., Murphy M. L. Cytosine arabinoside (NSC-63878) in acute leukemia in children. Cancer Chemother Rep. 1966 Jul;50(5):287–291. [PubMed] [Google Scholar]
  47. ISRAELS M. C., LEONARD B. J., WILKINSON J. F. Treatment of Hodgkin's granuloma, chronic lymphatic leukaemia, polycythaemia vera, and other reticuloses with triethylenethiophosphoramide. Lancet. 1956 Nov 17;271(6951):1017–1021. doi: 10.1016/s0140-6736(56)90268-9. [DOI] [PubMed] [Google Scholar]
  48. Iversen O. H. Kinetics of cellular proliferation and cell loss in human carcinomas. A discussion of methods available for in vivo studies. Eur J Cancer. 1967 Nov;3(4):389–394. doi: 10.1016/0014-2964(67)90023-0. [DOI] [PubMed] [Google Scholar]
  49. JOHNSON H. A., RUBINI J. R., CRONKITE E. P., BOND V. P. Labeling of human tumor cells in vivo by tritiated thymidine. Lab Invest. 1960 Jul-Aug;9:460–465. [PubMed] [Google Scholar]
  50. JOHNSON I. S., ARMSTRONG J. G., GORMAN M., BURNETT J. P., Jr THE VINCA ALKALOIDS: A NEW CLASS OF ONCOLYTIC AGENTS. Cancer Res. 1963 Sep;23:1390–1427. [PubMed] [Google Scholar]
  51. Jacquillat C., Boiron M., Weil M., Tanzer J., Najean Y., Bernard J. Rubidomycin. A new agent active in the treatment of acute lymphoblastic leukaemia. Lancet. 1966 Jul 2;2(7453):27–28. doi: 10.1016/s0140-6736(66)91751-x. [DOI] [PubMed] [Google Scholar]
  52. KIDD J. G. Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum. I. Course of transplanted cancers of various kinds in mice and rats given guinea pig serum, horse serum, or rabbit serum. J Exp Med. 1953 Dec;98(6):565–582. doi: 10.1084/jem.98.6.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Kennedy B. J., Yarbro J. W. Metabolic and therapeutic effects of hydroxyurea in chronic myeloid leukemia. JAMA. 1966 Mar 21;195(12):1038–1043. [PubMed] [Google Scholar]
  54. Kummer H., Bucher U. Erfahrungen mit einem neuen Cytostaticum der Methyl-Hydrazinreihe (Natulan). Mit besonderer Berücksichtigung der hämatologischen Nebenwirkungen. Schweiz Med Wochenschr. 1965 Sep 11;95(37):1233–1240. [PubMed] [Google Scholar]
  55. LARIONOV L. F., SHKODINSKAJA E. N., TROOSHEIKINA V. I., KHOKHLOV A. S., VASINA O. S., NOVIKOVA M. A. Studies on the anti-tumour activity of p-di-(2-chloroethyl) aminophenylalanine (sarcolysine). Lancet. 1955 Jul 23;269(6882):169–171. doi: 10.1016/s0140-6736(55)92736-7. [DOI] [PubMed] [Google Scholar]
  56. LEES A. W. ETHOGLUCIDE IN TREATMENT OF INOPERABLE LUNG CANCER. Br Med J. 1965 Jan 23;1(5429):230–231. doi: 10.1136/bmj.1.5429.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. MASHBURN L. T., WRISTON J. C., Jr TUMOR INHIBITORY EFFECT OF L-ASPARAGINASE FROM ESCHERICHIA COLI. Arch Biochem Biophys. 1964 May;105:450–452. doi: 10.1016/0003-9861(64)90032-3. [DOI] [PubMed] [Google Scholar]
  58. MATTHIAS J. Q., MISIEWICZ J. J., SCOTT R. B. Cyclophosphamide in Hodgkin's disease and related disorders. Br Med J. 1960 Dec 24;2(5216):1837–1840. doi: 10.1136/bmj.2.5216.1837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Malpas J. S., Scott R. B. Rubidomycin in acute leukaemia in adults. Br Med J. 1968 Jul 27;3(5612):227–229. doi: 10.1136/bmj.3.5612.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Manheimer L. H., Vital J. Mitomycin-C in the therapy of far-advanced malignant tumors. Cancer. 1966 Feb;19(2):207–212. doi: 10.1002/1097-0142(196602)19:2<207::aid-cncr2820190211>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  61. Mathé G., Schneider M., Schwarzenberg L. The time factor in cancer chemotherapy. Eur J Cancer. 1970 Feb;6(1):23–31. doi: 10.1016/0014-2964(70)90050-2. [DOI] [PubMed] [Google Scholar]
  62. Moertel C. G., Reitemeier R. J., Hahn R. G. Mitomycin C therapy in advanced gastrointestinal cancer. JAMA. 1968 Jun 17;204(12):1045–1048. [PubMed] [Google Scholar]
  63. NEUMAN R. E., MCCOY T. A. Dual requirement of Walker carcinosarcoma 256 in vitro for asparagine and glutamine. Science. 1956 Jul 20;124(3212):124–125. doi: 10.1126/science.124.3212.124. [DOI] [PubMed] [Google Scholar]
  64. Oettgen H. F., Old L. J., Boyse E. A., Campbell H. A., Philips F. S., Clarkson B. D., Tallal L., Leeper R. D., Schwartz M. K., Kim J. H. Inhibition of leukemias in man by L-asparaginase. Cancer Res. 1967 Dec;27(12):2619–2631. [PubMed] [Google Scholar]
  65. PHILIPS F. S., THIERSCH J. B. The nitrogen mustard-like actions of 2,4,6-tris (ethylenimino)-s-triazine and other bis(ethylenimines). J Pharmacol Exp Ther. 1950 Dec;100(41):398–407. [PubMed] [Google Scholar]
  66. PINKEL D. Actinomycin D in childhood cancer; a preliminary report. Pediatrics. 1959 Feb;23(2):342–347. [PubMed] [Google Scholar]
  67. PRUSOFF W. H., LAJTHA L. G., WELCH A. D. Effect of the deoxyriboside of 6-azathymine (azathymidine) on the biosynthesis of deoxyribonucleic acid by bone marrow and neoplastic cells (in vitro). Biochim Biophys Acta. 1956 Apr;20(1):209–214. doi: 10.1016/0006-3002(56)90279-7. [DOI] [PubMed] [Google Scholar]
  68. Perry S., Thomas L. B., Johnson R. E., Carbone P. P., Haynes H. A. Hodgkin's disease. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med. 1967 Aug;67(2):424–442. doi: 10.7326/0003-4819-67-2-424. [DOI] [PubMed] [Google Scholar]
  69. Ream N. W., Perlia C. P., Wolter J., Taylor S. G., 3rd Mithramycin therapy in disseminated germinal testicular cancer. JAMA. 1968 Jun 17;204(12):1030–1036. [PubMed] [Google Scholar]
  70. SHAY H., ZARAFONETIS C., SMITH N., WOLDOW I., SUN D. C. Treatment of leukemia with triethylene thiophosphoramide (thio-TEPA); preliminary results in experimental and clinical leukemia. AMA Arch Intern Med. 1953 Nov;92(5):628–645. doi: 10.1001/archinte.1953.00240230028004. [DOI] [PubMed] [Google Scholar]
  71. Steel G. G. Cell loss as a factor in the growth rate of human tumours. Eur J Cancer. 1967 Nov;3(4):381–387. doi: 10.1016/0014-2964(67)90022-9. [DOI] [PubMed] [Google Scholar]
  72. Tallal L., Tan C., Oettgen H., Wollner N., McCarthy M., Helson L., Burchenal J., Karnofsky D., Murphy M. L. E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children. Cancer. 1970 Feb;25(2):306–320. doi: 10.1002/1097-0142(197002)25:2<306::aid-cncr2820250206>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  73. VAITKEVICIUS V. K., BRENNAN M. J., BECKETT V. L., KELLY J. E., TALLEY R. W. Clinical evaluation of cancer chemotherapy with 5-fluorouracil. Cancer. 1961 Jan-Feb;14:131–152. doi: 10.1002/1097-0142(196101/02)14:1<131::aid-cncr2820140118>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  74. VERCILLO L., ESPOSITO S. Aspetti farmacologici ed impiego clinico della desacetilmetilcolchicina nella terapia delle emopatie maligne; rassegna della letteratura e contributo personale. Haematologica. 1958;43(5):345–384. [PubMed] [Google Scholar]
  75. WEISS A. J., JACKSON L. G., CARABASI R. An evaluation of 5-fluorouracil in malignant disease. Ann Intern Med. 1961 Nov;55:731–741. doi: 10.7326/0003-4819-55-5-731. [DOI] [PubMed] [Google Scholar]
  76. WELCH A. D. Some metabolic approaches to cancer chemotherapy. Cancer Res. 1961 Dec;21:1475–1490. [PubMed] [Google Scholar]
  77. WHITELAW D. M., COWAN D. H., CASSIDY F. R., PATTERSON T. A. CLINICAL EXPERIENCE WITH VINCRISTINE. Cancer Chemother Rep. 1963 Jul;30:13–20. [PubMed] [Google Scholar]
  78. WILTSHAW E. CHLORAMBUCIL IN THE TREATMENT OF PRIMARY ADENOCARCINOMA OF THE OVARY. J Obstet Gynaecol Br Commonw. 1965 Aug;72:586–594. doi: 10.1111/j.1471-0528.1965.tb00068.x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES